Sign in

Albemarle Corporation ALB

Price 132.2 USD
as of 2026-09-05
49/100
Mixed
Quality36
Growth59
Balance-sheet strength71
Valuation49
Momentum33
Income49

Composite 49/100; the shares have moved about 54% annualised. Names that move more contribute more risk for the same amount invested, and our composite reflects how strong the evidence for this one is right now.

Strongest counter-signal

Momentum ranks 33/100 — a moderate mark against it.

Case for

Balance-sheet strength ranks 71/100 — a moderate point in its favour. Growth ranks 59/100 — a slight point in its favour.

Case against

Momentum ranks 33/100 — a moderate mark against it. Quality ranks 36/100 — a moderate mark against it. Valuation ranks 49/100 — a slight mark against it.

What the company does Albemarle Corporation produces lithium compounds for batteries, greases, and specialty glass, and bromine-based chemicals for fire safety, mobility, and health applications.

Key financials Albemarle’s trailing P/E is 497.33 versus a forward P/E of 17.83, PEG 0.79, and EV/EBITDA 18.39. Margins: gross 24.0%, operating 27.7%, net 3.8%. ROE 2.6%, ROA 3.2%, ROCE 3.1%. Debt/Equity 0.19, net debt/EBITDA 0.25, interest coverage 2.53, current ratio 2.09.

Stock health Overall Sideravia score 49.2 (Weak quality, fairly valued, weak momentum). Quality 36.9, Growth 59.3, Strength 72.4, Valuation 46.1, Momentum 32.9, Income 48.3. Piotroski F-Score 5/9, Altman Z 2.83. Dividend yield 1.2%, payout 27.2%.

Price vs fair value The stock trades at a discount of 30.30% versus the analyst mean target of 173.56. - Forward P/E 17.83 is below the trailing P/E 497.33 (company data). - Net margin 3.8% is below sector averages (Sideravia). - Momentum score 32.9 is weak despite 65.95% 12-month return (Sideravia). - Debt/Equity 0.19 and current ratio 2.09 indicate moderate leverage and liquidity (company data).

sideravia.comEvery stock argues both sides.
Research, not advice · sideravia.com/conflicts — read the policy

This is not investment advice. Sideravia provides automated, data-driven analysis for information and education only. Nothing on this page is a personal recommendation or an invitation to buy or sell any security, and it does not consider your objectives or financial situation. Assessments are generated by rules applied uniformly to every covered stock — how our scores work.

Data as of 2026-09-05, compiled from third-party sources; errors and delays are possible and figures are not warranted. Investing puts your capital at risk; past performance does not predict future results. We publish our full track record, including the calls that lost, and our conflicts of interest.